|
Speaker Biographies
|
|
Robin Abrams
Vice President, Associate General Counsel
Purdue Pharma L.P. |
 |
Robin E. Abrams is Vice President, Associate General Counsel, at Purdue Pharma L.P., where she has worked since July 2002. In this role, Robin’s responsibilities include handling government investigations, legal and regulatory issues related to controlled substance compliance (including order monitoring) and various other litigation and compliance areas.
Before joining Purdue, Robin spent 11 years at the United States Attorney’s Office for the Southern District of New York. During her tenure there, Robin was an Assistant United States Attorney, the Health Care Fraud Coordinator for the Criminal Division and, during her last two years, Deputy Chief of the Criminal Division. While an Assistant United States Attorney, Robin handled numerous multi-defendant criminal jury trials as well as appeals to the Court of Appeals for the Second Circuit. During her tenure Robin also was responsible for the creation and management of a group of attorneys that focused upon criminal health care fraud investigations and prosecutions.
Academically, Robin received her Bachelor of Arts in History and Government from Cornell University in 1986, where she graduated with Distinction. Thereafter she received her law degree from New York University School of Law in 1989, where she graduated Magna cum Laude. Robin also attended Oxford University in England from 1984–1985. From 1990–1991, Robin clerked for the then-Chief Judge of the United States District Court for Eastern District of New York, the Honorable Jack B. Weinstein. |
|
|
Chris J. Anderson
Director, Quality and Regulatory Affairs
Cardinal Health, Inc. |
 |
Chris Anderson has been with Cardinal Health, Inc. since 1987 in Quality and Regulatory Affairs at both the field and corporate levels, and is responsible for wholesale drug distribution compliance. Over the past five years he has managed the project development of a new quality system for Cardinal Health’s Pharmaceutical Distribution operations and has led projects to select, standardize and deploy a qualified refrigerated pharmaceutical packaging process. In his current role, Anderson manages the Quality System functions for corporate Pharmaceutical Distribution and is responsible for cold chain packaging; the document center; and compliance reporting and tracking websites such as the CAPA system. He holds a BA in Political Science from Norwich University and a MA in Organizational Behavior. |
|
|
Daniel G. Bellingham
Senior Director, State Government Affairs
HDMA |
 |
Daniel G. Bellingham is Senior Director, State Government Affairs at HDMA. Bellingham is currently responsible for state advocacy efforts at both the legislative and regulatory levels and has been with HDMA since 2002. Prior to joining HDMA, he covered healthcare issues for corporate and association clients as a legislative analyst at Stateside Associates, a state legislative and regulatory monitoring company. He also has experience as a legislative associate in the Oregon legislature. Bellingham holds a BA in Political Science from the University of Oregon. |
|
|
Bob Beckel
Co-Author, USA Today’s “Common Ground” Column |
 |
Liberal Bob Beckel, one of Washington’s top political analysts, began his career in politics in 1968 working for Robert F. Kennedy’s campaign. He worked in the White House as a Deputy Assistant Secretary of State for the Carter administration and was Campaign manager for Walter Mondale. For the past several years, Beckel has had an active consulting practice, and advises his clients on communication strategy, consensus building and public policy. He appears regularly on television as an analyst, working on CNN and for CBS This Morning. Beckel has also been a regular contributing columnist for the Los Angeles Times for the last three presidential campaigns. |
|
|
Rob Brown
Vice President, Sales
Cardinal Health Specialty Solutions |
| |
Rob Brown leads the sales efforts of the distribution business for Cardinal Health Specialty Solutions, including specialty distribution and third-party logistics. His team focuses on selling distribution solutions to the company’s physician office and acute care customers. Brown’s sales team, made up of field based, inside sales and customer service teams, covers a range of therapeutic areas including oncology, rheumatology, nephrology and plasma.
Brown has been involved in sales and marketing associated with healthcare logistics for the past 10 years. In September 2003, he joined Cardinal Health as a Director of Sales and has taken on ever increasing responsibilities. Over the past eight years, his roles and responsibilities have included many aspects of the specialty business including account management, marketing, reimbursement and specialty pharmacy.
Prior to joining Cardinal Health, Brown led the North American healthcare practice for Kuehne & Nagel, one of the largest third-party logistics providers in the U.S. At Kuehne & Nagel he was responsibile for providing international contract logistics and transportation services for several of the industry’s leading healthcare manufacturers.
Brown earned a BA from The College of William & Mary and is an active member of the Specialty & Biotech Distributors Council for the Healthcare Distribution Management Association. |
|
|
Terry Carrico Vice President, Corporate Security
McKesson Corporation |
 |
Terry Carrico is Vice President of Corporate Security and Safety Operations for McKesson Corporation. In this role, he is responsible for leading all aspects of security and safety operations, including program development in the areas of security and safety standards, physical security, supply chain security, security awareness and workplace violence prevention. Prior to joining McKesson in 2007, Carrico was employed by Pfizer as the Director of Global Asset Protection. In 2003 he retired from the U.S. Army Military Police Corps as a Colonel after 24 years of service. Carrico holds a BS in Criminal Justice from Eastern Kentucky University and an MS in Forensic Science from The George Washington University. |
|
|
David Colombo Serialization Program Leader
Lilly USA, LLC |
 |
Dave Colombo is the Serialization Program Leader for Eli Lilly and Company. His current responsibilities include defining Lilly’s serialization program strategy and coordinating solution deployment at manufacturing and distribution facilities globally in response to the various country-level serialization and traceability initiatives around the world. He has held numerous technical and leadership positions at Lilly during his 21 years with the company, primarily supporting operations and projects in the supply chain and distribution components. Dave received his BS in Industrial Engineering from Purdue University and an MBA with a concentration in Operations Management from Indiana University. |
|
|
Michael C. Cotugno B.S., R.Ph. Director of Pharmacy Patient Care Services
Brigham and Women’s Hospital |
 |
Michael is currently the Director of Pharmacy Patient Care Services at Brigham and Women’s Hospital in Boston. Michael has worked at Brigham and Women’s Hospital for 20 years, holding positions as a clinical pharmacist and pharmacy supervisor before becoming Director of Pharmacy Patient Care Services. Michael has been part of the Brigham and Women’s Hospital decision and implementation teams that have directed computerized physician order entry, use of automated-dispensing cabinets, barcode scanning technology, the electronic medication administration record, medication reconciliation, disaster planning and robotically prepared sterile products. |
|
|
Ed Crimmins
Partner
Kindler & Crimmins Associates, LLC |
 |
Ed is a founding partner of Kindler & Crimmins Associates, LLC (KCA). Established in January 2011, KCA is an independent consulting firm with broad-based experience and expertise in the areas of pharmaceutical inventory management and reverse logistics.
Ed is a 12-year veteran of the drug store industry, having most recently served as Senior Director of Pharmacy Inventory & Returns for the Rite Aid Corporation. In that role, he was responsible for the oversight of store pharmaceutical inventory as well as the pharmaceutical reverse logistics function.
Ed joined Rite Aid in 1998 as an Inventory Control Manager and served in a variety of capacities in Distribution, Logistics and Inventory Management. Ed has been active working as a retail representative for HDMA’s Return Task force, serving as a member of the Looking Forward in Reverse Logistics seminar steering committee and a panelist at numerous HDMA conferences. He also participated in the development of HDMA’s Understanding the Drivers of Expired Pharmaceutical Returns report. |
|
|
Greg Drew, RPh President
Value Drug Company |
 |
Greg Drew is President of Value Drug Company, a pharmaceutical wholesaler operating out of Altoona, Pennsylvania. His current role involves oversight of all aspects of the business of Value Drug Company, which is a cooperative concept organization, with its shareholders being owners of independent community pharmacies. He has been in this position since October of 2009.
Previously, Greg headed a consulting business, Pharmacy Expertise, LLC, providing guidance to pharmaceutical companies and managed care organizations on pharmacy matters. Mr. Drew had spent the prior 15 years with Rite Aid Corporation in various roles, including Vice President of Clinical Services at Eagle Managed Care, a PBM subsidiary, Vice President of Pharmacy Health Services and Vice President and General Manager of Rite Aid Health Solutions up until October of 2008. In these positions, responsibilities included clinical strategy and operations management, adherence programs, manufacturer program contracting, governmental special programs, PBM operations, pharmacy marketing and key external relationship management.
Greg is a 1981 graduate of Massachusetts College of Pharmacy and Allied Health Sciences, a registered pharmacist, and an Adjunct Associate Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. |
|
|
Caroline Dunn
Engagement Manager
IMS Strategic Partnerships |
| |
Caroline Dunn is a consultant with more than 10 years’ experience in the pharmaceutical sector. Her role is in the IMS Global Strategic Partnerships team, and she supports the IMS relationship-building program with key market stakeholders.
Most recently Caroline has focused on researching developments in worldwide distribution and dispensing of pharmaceuticals. Her interests include analyzing new trends in the distribution and dispensing sector, the impact of the financial crisis on the pharmaceutical market, the international comparison of pharmaceutical prices and pricing mechanisms, as well as new supply chain technology and integrity developments.
Previously Caroline worked as both a management and information consultant. Covering a number of subject matters, she has specific expertise in pricing, reimbursement and market access topics, parallel trade, market forecasting and sizing and the international comparison of pharmaceutical issues. She also specializes in such technology-focused issues as data-management strategies, data-quality management and the formation and dissemination of meaningful organizational key performance indicators.
Before joining IMS, Caroline was an accountant. She trained with the National Health Service in the UK, working in a number of financial management roles in hospitals, primary care organizations and with the departed of health. |
|
|
David L. Durkin, Esq.
Principal
Olsson Frank Weeda Terman Bode Matz PC |
 |
David Durkin is a Principal at Olsson Frank Weeda Terman Bode Matz P.C. He has been with the firm since 1988. Durkin's practice is concentrated in federal civil and criminal litigation and administrative proceedings, including court challenges to FDA, USDA, DEA regulatory and enforcement initiatives and ITC proceedings. Prior to joining the firm, Durkin served a two-year appointment as Law Clerk to the Honorable Jaime Pieras, Jr., United States District Judge for the District of Puerto Rico. He received his bachelor’s degree in Philosophy from John Carroll University, and holds a JD from the Catholic University of America. |
|
|
Kimberly Fleming Senior Manager, Product Security
EMD Serono |
 |
Kimberly Fleming, Senior Manager, Product Security, has been with EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, for ten years and has held various positions of increasing responsibility. Her experiences include assignments in warehousing/distribution, supply logistics, secure distribution and most recently leading the product security efforts. Mrs. Fleming's current responsibilities are to ensure that EMD Serono products are secure within the various commercial supply distribution channels, complying with current and future regulations and oversight of EMD Serono’s portfolio of secure distribution products. She also led the global efforts for the US in driving an e-pedigree/serialization initiative forward to complete the operational aspects for the commercial products. This work included both current and future products. In addition, she is actively involved with key customer pilots and implementation initiatives. Mrs. Fleming has presented at trade association and government meetings to share EMD Serono views and accomplishments relating to promoting a more secure supply chain and driving patient safety. |
|
|
Elizabeth A. Gallenagh, Esq.
Vice President, Government Affairs and General Counsel
HDMA |
 |
Elizabeth A. Gallenagh, Esq. is the Vice President, Government Affairs and General Counsel for HDMA. She is responsible for overseeing federal and state advocacy on behalf of HDMA member companies and is the organization’s chief in-house attorney. Additionally, she serves as HDMA’s primary legislative expert on prescription drug pedigree, licensure and tax issues. Prior to joining HDMA, Gallenagh specialized in Medicare Part B reimbursement and coverage policy, fraud and abuse investigations and federal anti-kickback law. Earlier, Gallenagh also served as Legislative Assistant to Congressman Tom Manton (D-N.Y.) Gallenagh holds a JD from the George Mason University School of Law, and a BA from The George Washington University. |
|
|
John M. Gray
President and CEO
Healthcare Distribution Management Association |
 |
John M. Gray is President and CEO of the Healthcare Distribution Management Association, the national association representing primary healthcare distributors. He reports directly to the HDMA Board of Directors and is responsible for overseeing all HDMA operations and activities. Gray also serves as President and CEO of the Center for Healthcare Supply Chain Research, formerly the HDMA Foundation.
Prior to joining HDMA, he served as Food Distributor International’s (FDI’s) Executive Vice President and General Counsel. When FDI merged with the Food Marketing Institute, Gray became the President and CEO of the International Food Distributors Association (IFDA).
Gray holds an AB from the College of William and Mary; an MBA from the Wharton School, University of Pennsylvania; and a JD from the University of Virginia School of Law. |
|
|
Ron Greene Vice President of Strategic Global Operations
Freightwatch USA |
 |
Ron Greene is Vice President of Strategic Global Operations and has held this position since July 2011. He is responsible for operational strategy, product development and global operations. Ron joined the company in 2007 and has held the positions of Vice President, General Manager of FreightWatch USA and Senior Director of Commercial Development for FreightWatch USA.
Prior to FreightWatch, Ron served as a supply chain security consultant and logistics manager in the supply chain security division for First Advantage Corporation, working for Fortune 100 companies by building and managing global logistics security programs. Ron’s professional tenure also includes logistics management and engineering. Additionally, he spent two years with the Peace Corps in Ukraine in a business development role.
Ron holds a dual major in Engineering and Economics from Grand Valley State University, and a master’s degree in Finance from Thunderbird School of Global Management. |
|
|
Joanne S. Hawana, JD Attorney
Arent Fox, LLP |
 |
Joanne S. Hawana is an associate in the Food and Drug Practice Group at Arent Fox LLP in Washington, D.C. Joanne focuses her practice on government oversight of foods, drugs and devices, as well as wholesale distribution and pharmacy activities regulated by the states. She frequently works with manufacturer and distributor clients regarding their licensing obligations at the state and local level. Joanne holds a BS in biology from The College of William & Mary, an MS in molecular genetics and microbiology from the University of Medicine and Dentistry of New Jersey and a JD from the University of Maryland School of Law. |
|
|
Susan Higgins Principal
Booz & Company |
 |
Susan E. Higgins is a Principal in Booz & Company’s Global Operations Practice. Ms. Higgins specializes in supply chain and operations strategy for clients in the pharmaceutical and consumer health industries. Ms. Higgins has in-depth knowledge of both the pharmaceutical manufacturing and distribution industries and led the 2010 U.S. Pharmaceutical Track and Trace Study and the 2011 Role of the Distributor in the U.S. Healthcare Industry study published by HDMA and the Center for Healthcare Supply Chain Research. |
|
|
Dave Janca President and CEO
ValueCentric, LLC |
 |
Dave Janca is the founder and CEO of ValueCentric. As the leader in connected healthcare intelligence, the company’s mission is to provide unprecedented market insights and enhanced business relationships through shared actionable information. Under Dave’s guidance, ValueCentric has helped to reshape the face of healthcare intelligence by changing the scope, timeliness and accessibility of information resulting in improved business performance. Today, more than 200 marquee customers from throughout the healthcare spectrum utilize ValueCentric services.
Dave developed a keen understanding of the healthcare industry while serving as Vice President of Purchasing at Cardinal Health. His ten years of experience there led to the founding of Supply Chain Solutions, which was acquired in 2000 by NonStop Solutions (now Manhattan Associates). Supply Chain Solutions’ innovative SCORE product still remains the standard for replenishment activities in the drug distribution industry. With multiple entrepreneurial successes under his belt, Dave has provided thought leadership not only to his ventures, but to the industry at large. |
|
|
Gayle Johnson President
CuraScript SD Specialty Distribution, an Express Scripts Company |
 |
Gayle Johnston is President of CuraScript Specialty Distribution, a wholly owned subsidiary of Express Scripts. She has profit and loss responsibility for this distributor of specialty injectable and infusible pharmaceuticals. Her leadership has been instrumental in setting Specialty Distribution’s strategic direction and alignment with Express Scripts, and enhancing business process, productivity and efficiency. She joined Express Scripts in 2003 as Vice President of Operations for Specialty Distribution Services and was promoted to Vice President & General Manager of Operations for CuraScript Specialty Pharmacy two years later.
Prior to Express Scripts, Gayle spent six years at Baxter Healthcare Corporation — first as the Vice President, General Manager of Pharmacy Access and later as the General Manager, Marketing and Operations for the U.S. Region of IV Systems and Medical Products. During her tenure at Baxter, she was credited for driving sales and manufacturing efficiencies, launching two new product/service categories and customer service initiatives, which resulted in significant increases in sales and gross margin for the Division. Gayle has previously been employed in a variety of Sales and Marketing positions at Bausch & Lomb, Bristol Myers-Squibb and American Hospital Supply Corporation (now Cardinal Health).
Gayle earned both her Bachelor of Science and Master of Science degrees from Purdue University. |
|
|
Alexander Kandybin, PhD
Vice President, Global Health Practice
Booz & Company |
 |
Alexander Kandybin, PhD, is a Vice President in Booz & Company’s Global Health Practice. Dr. Kandybin specializes in portfolio growth and innovation strategy and has in-depth knowledge of both the pharmaceutical manufacturing and distribution industries. Alex has significant experience leading research projects for HDMA and the Center for Healthcare Supply Chain Research, including the 2004 and 2007 editions of the Role of Distributors in the U.S. Healthcare Industry, HDMA’s 2009 Future of Healthcare Study and the 2010 U.S. Pharmaceutical Track and Trace Study (published by HDMA and the Center). |
|
|
Kevin Kannally
Vice President, Corporate Operations
Cardinal Health, Inc. |
 |
Kevin Kannally is Vice President of Corporate Operations, a position he has held since August 2007. In this role, he is responsible for optimizing the Pharmaceutical Distribution (PD) supply chain as well as developing solutions and adding value across the entire healthcare supply chain.
Prior to this role, Kevin was Vice President of Operations for the company’s Healthcare Supply Chain Services business with responsibility for the National Logistics Center (NLC) and General Merchandise Logistics Center, which provided an expanded front-of-store offering for retail independent customers.
Kevin also served as Director of Operations for the Swedesboro and Wheeling PD facilities and as Director of Operations for the NLC.
Kevin began his career in the Navy where he served six years in a variety of roles, including overseeing the supply needs for the West Coast submarine fleet and Naval Air Stations. Kevin also spent five years at Borden Incorporated in their Credit and Collections department.
Kevin holds a bachelor’s of Business Administration and Finance from the University of San Diego and serves on the board of the Columbus Regional Supply Chain Council. |
|
|
Andy Keller Vice President, Inventory Management
Cardinal Health |
 |
Andy Keller is currently Vice President of Inventory Management for Cardinal Health’s Pharmaceutical Distribution Business. He is responsible for customer service levels and managing inventory across the pharmaceutical supply chain.
Andy has a breadth of experience in supply chain and technology roles in the healthcare, automotive, multi-channel retail and outsourcing industries. He earned his undergraduate degree in Business from Miami University and his MBA from The Ohio State University.
He is a Past President of Columbus Roundtable and currently serves on the Educational Strategies Committee for the Council of Supply Chain Professionals. |
|
|
Stephen Kindler Partner
Kindler & Crimmins Associates, LLC |
| |
Steve is a founding partner of Kindler & Crimmins Associates, LLC (KCA). Established in January 2011, KCA is an independent consulting firm with broad-based experience and expertise in the areas of pharmaceutical inventory management and reverse logistics.
Prior to starting KCA, he served as Vice President of Inventory Management for the Rite Aid Corporation, where he was responsible for managing all facets of Rite Aid’s company-wide inventory investment, primarily focusing on store inventory, as well as the pharmaceutical and HBA/OTC reverse logistics functions.
During his tenure, Steve took the lead in developing and implementing related inventory and return- related policies and procedures and was instrumental in designing and implementing various programs and initiatives that helped improve Rite Aid’s inventory productivity, reduce return volume and significantly increase overall profitability.
Steve joined Rite Aid in 1990 as an Accounts Payable Manager and served in a variety of capacities in the areas of finance, accounting, pharmacy services, logistics and category management.
Prior to joining Rite Aid, Steve worked as a supervising auditor for the public accounting firm KPMG Peat Marwick.
Steve holds an Accounting degree from Susquehanna University. |
|
|
Doug Long
Vice President Industry Relations
IMS Health, Inc. |
 |
Doug Long is Vice President of Industry Relations at IMS Health, the world’s largest pharmaceutical information company. IMS Health provides consulting services and an extensive product portfolio to the pharmaceutical industry in more than 101 countries worldwide. Since joining IMS in 1989, Doug has been active in the successful implementation of data health databases and has a unique perspective on the changing U.S. and global healthcare marketplace and pharmaceutical distribution. Doug Long’s Industry Year in Review features trends and forecasts of the U.S. market. Wholesalers, retailers, manufacturers and multiple trade associations rely on Doug for guidance, direction and industry expertise.
Doug is a frequent industry speaker and permanent member of the Editorial Advisory Board of HealthCare Distributor magazine. He was a recipient of the 2004 Nexus Award for Lifetime Achievement and IMS’ prestigious Summit Award in 2003.
Prior to IMS Health, Doug was at Nielsen Market Research for 16 years in sales and marketing capacities. A native of Illinois, Doug received a BA from DePauw University and an MBA from Fairleigh Dickinson University. |
|
|
Kevan MacKenzie
Senior Solutions Analyst
McKesson Corporation |
 |
Kevan MacKenzie is Senior Solutions Analyst and Six Sigma Blackbelt in the Business Technology Solutions Group at McKesson Pharmaceutical. His responsibilities include McKesson’s initiatives in serialization, e-Pedigree, radio frequency identification (RFID), electronic product code, barcode identification and supply chain security. He also is a business technology liaison with McKesson’s Corporate Government Affairs. MacKenzie holds an MBA from Auckland University, New Zealand. |
|
|
Colin Maiorano
CEO
StrategyWorx |
 |
Through his company, StrategyWorx, Colin Maiorano consults with clients to create, communicate and execute creative strategies for finding agreement when people don’t see eye to eye.
Colin coaches clients to utilize several negotiating tools and techniques to prepare for and successfully reach the most favorable outcome, including how to create more and better options, differentiate goals from concerns, expand the list of negotiables, break impasses and get difficult deals done.
Colin has been providing consulting, training and coaching to Fortune 100 companies, private companies, government bodies and non-profits for more than 20 years. He specializes in strategy, process and leadership as well as negotiation; his clients include Eli Lilly, Hewlett-Packard and Proctor and Gamble.
Additionally, Colin has worked with clients in China, Singapore, France, Austria, Portugal, Sweden and Canada. He authored the book Confident, Credible and Clear — Designing and Delivering Well-Organized, Persuasive Presentations, as well as numerous magazine articles. Colin also has provided business insight for National Public Radio. |
|
|
Mark Parrish
President
International Federation of Pharmaceutical Wholesalers |
 |
Mark Parrish, currently President of the International Federation of Pharmaceutical Wholesalers (IFPW), also serves as Chairman and Chief Executive Officer of TridentUSA Health Services, a privately held long-term care services company providing mobile x-ray and laboratory services to skilled nursing facilities. TridentUSA Health Services is the largest provider of these services in the United States. Mr. Parrish serves on the Board of Directors of several Private Companies and at Mylan Crporation, where he serves on the Board of Directors and is Chairperson of the Compliance Committee. Additionally, he serves as Senior Advisor, Growth Equity at Frazier Healthcare Ventures. Mr. Parrish was Chief Executive Officer of Healthcare Supply Chain Services for Cardinal Health Inc., an $87 billion global manufacturer and distributor of medical and surgical supplies and technologies, publically traded on the NYSE, from November 2006 to 2007. Cardinal Health’s customers are located on five continents and include hospitals, medical centers, retail and mail-order pharmacies, clinics, physicians, pharmacists and other healthcare providers. Mr. Parrish also served in a number of other roles at Cardinal Health Inc., including as Group President, Pharmaceutical Supply Chain Services from August 2006, President and Chief Operating Officer, Pharmaceutical Supply Chain Services from September 2005 to August 2006, Chairman and Chief Executive Officer, Pharmaceutical Distribution and Provider Services from August 2004 to September 2005, Executive Vice President and Group President, Pharmaceutical Distribution from January 2003 to August 2004 and President, Medicine Shoppe, a subsidiary of Cardinal Health Inc., from July 2001 to January 2003. Mr. Parrish holds a Bachelor of Arts degree from the University of California, Berkley. |
|
|
Kelly Picard
Chief Sales Officer
Hackbarth Delivery Service |
 |
Kelly Picard has been in a leadership role with Hackbarth Delivery Service since 1994. In her current position as Chief Sales Officer, she is responsible for execution of growth strategies and business development. Prior to creating the sales department, Kelly worked in Operations, managing terminal locations in the southeast. Before joining Hackbarth, she worked for a university in San Marcos, Nicaragua, after receiving a BA in International Politics and Spanish. She is currently working on an MBA at The Ohio State University. She is a member of several industry trade associations, including CSCMP, ECA, MCAA, Mobile Area Chamber of Commerce, Mobile United, and the Southeastern Warehouse Association. |
|
|
Alan Ralph
Managing Director of Healthcare Supply Chain
United Drug |
 |
Alan has been a Board Director of United Drug plc since June 2008. He also is the Managing Director of the group’s largest division, the Healthcare Supply Chain Division. United Drug provides commercialization solutions to international healthcare companies, specializing in supply chain, packaging, sales and marketing, medical and regulatory services. The group employs more than 4,500 people and its main operations are in the UK, US, Ireland and the Netherlands. Alan joined United Drug in 1999, and has held various roles throughout the group, including Managing Director of the Pharma Wholesale business. Prior to joining the company, Alan worked with Banta Corporation and PWC. |
|
|
Miguel Rodriguez
Senior Manager, Strategy and Business Development
CuraScript SD Specialty Distribution, An Express Scripts Company |
 |
Miguel Rodriguez is Senior Manager of Strategy and Business Development at CuraScript SD Specialty Distribution, An Express Scripts Company. In his role, he is responsible for research and development of new business opportunities, development and execution of market segment strategies (including product mix, promotion and pricing) and presenting those segment strategies to various levels of leadership within the pharmaceutical community. Miguel was directly responsible for establishing the Strategy and Business Development department at CuraScript Specialty Distribution in 2007. His leadership in developing CuraScript Specialty Distribution’s Oncology strategy was instrumental in the company’s 38 percent year over year Oncology business growth in 2011. Miguel also was responsible for establishing the Pharmacy Care Alliance Medicare Discount Card Program in 2004.
Since joining Express Scripts in 2000, Miguel has held several progressive positions of leadership including project management, account management, contact center management and new business development.
Miguel received his undergraduate degree in Public Relations from Temple University and his master’s in Business Administration from La Salle University. |
|
|
Dr. Larry J. Sabato
Director, Center for Politics, and Robert Kent Gooch Professor of Politics
University of Virginia |
 |
At home both in the classroom and the television studio, Dr. Sabato bridges the gap between the ivory tower and the real world of politics. He is a University Professor of Politics and Director of the University of Virginia Center for Politics and is the author of 24 books and countless essays on politics, including the well-known Feeding Frenzy; A More Perfect Constitution; and, The Year of Obama. Dr. Sabato’s latest book is the newly released volume on the 2010 midterm elections, Pendulum Swing.
A Rhodes Scholar, Dr. Sabato has taught more than 15,000 students in his career at Oxford University, Cambridge University and the University of Virginia. He has received every major teaching award at the University of Virginia. In 2001 he was named the Thomas Jefferson Award winner, U.Va's highest honor, which is given to one person each year. |
|
|
Larri Short
Partner, Health Law Group
Arent Fox LLP |
 |
Larri Short, Esq. is a Partner in the Health Law Group at Arent Fox LLP. Larri focuses on healthcare regulatory matters, including Medicare and Medicaid reimbursement; Medicaid and state supplemental drug rebate programs; PHS and VA pricing; fraud and abuse; and sales, marketing and clinical trial compliance issues. She has represented healthcare provider and pharmaceutical clients in qui tam actions filed under federal and state False Claims Acts and is involved in the defense of pharmaceutical clients. Larri holds a BS from the University of Michigan, an MA from Duke University and a JD from the University of North Carolina School of Law. |
|
|
Boyd Stephenson
Manager, Safety & Security Operations
American Trucking Association |
 |
Boyd Stephenson is the American Trucking Associations’ Manager for Safety and Security Policy, supporting ATA’s Homeland Security and Safety Policy Committees. He works with the Department of Transportation and its modal agencies; the Transportation Security Administration (TSA); and, other government agencies to ensure that programs and rules are implemented in a manner that strengthens transportation safety and security without compromising operational efficiencies in the trucking sector.
At ATA, he is responsible for Driver Health and Medical Issues, Licensing and Training, Air Cargo Security, the Corporate Security Review program, all-hazards preparedness and the Transportation Worker Identification Credential. Additionally, he serves as the Chairman of the Highway Sector Coordinating Council, the highway mode’s primary voice to TSA on security matters, and participates in the National Level Exercise and other government sponsored preparedness activities as the representative of the Highway Sector. Boyd joined ATA in July 2007.
Before joining ATA, Boyd worked at United Parcel Service in their Office of Public Affairs, where he focused on postal service operations and surface and maritime transportation. Boyd also has experience working on political campaigns in Florida and Arkansas. Boyd graduated from Davidson College in Davidson, N.C., in 2003 with a degree in Political Science. He lives in Washington, D.C. |
|
|
Cal Thomas
Co-Author, USA Today’s “Common Ground” Column |
 |
Conservative Cal Thomas is one of the most widely read and highly regarded voices of the political scene. He has a twice-weekly column appearing in more than 500 newspapers nationwide, and is a panelist on the popular Fox News Watch show. Thomas is a veteran of both broadcast and print journalism. He has worked for NBC, CNBC, PBS and the Fox News Network. For his work, he has received a George Foster Peabody team reporting award, and awards from the Associated Press and United Press International. Thomas is also the author of ten books, including The Wit and Wisdom of Cal Thomas, Blinded by Might: Can the Religious Right Save America? and Liberals for Lunch. |
|
|
David Ulrich
QA Director – Distribution
Abbott Laboratories |
 |
Dave Ulrich is the QA Director for Distribution and Logistics for Abbott’s Global Pharmaceutical Operations (GPO) division. His responsibilities include standardization and optimization of supply chain quality systems (cGDPs), supply chain temperature management, e-pedigree/track and trace, serialization and import-export compliance activities. Dave was a laboratory manager at a Chicago hospital before coming to Abbott in 1987. His 24 years at Abbott have been spent in bulk (API) manufacturing operations, manufacturing QA and plant maintenance, validation and engineering. He has spent the last six years in a quality function as part of Abbott’s supply chain. |
|
|
Ed Vianco, CPA
Vice President and Controller
McKesson Pharmaceutical Supply Solutions |
 |
Ed Vianco is a CPA and Vice President and Controller for McKesson Pharmaceutical Supply Solutions. He has more than 25 years of experience in various accounting and finance roles. Vianco is a current member and past chairman of the Center for Healthcare Supply Chain Research’s Industry Benchmarking Committee. Prior to his 14 years at McKesson, he served as an Audit Manager at KPMG, a Big Four national accounting firm; Vice President of Finance for a regional home healthcare company; and, as a Controller for a national real estate and hotel management company. Vianco holds a BBA and an MBA from Baylor University. |
|
|
Neil Warren
Cascade Pharma Solutions |
 |
Neil Warren recently retired as Vice President of Industry and Supplier Relations at Cardinal Health, Inc., a position he has held for nearly 10 years. With more than 25 years’ experience in the industry, much of his time has been spent at Cardinal or Cardinal-acquired companies. Today, Neil is Cascade Pharma Solutions, assisting all suppliers (Brand, Generic and Consumer Health) in communicating messages, developing value-added solutions and programs and directing problem resolution. He is a subject-matter expert on terms and conditions inherent to wholesale purchasing agreements, returns policies, supply chain distribution and distribution of new product launches to market. Neil has been the recipient of many prestigious awards and honors throughout the years, including HDMA’s Innovation for Success Award, the Cardinal Health Robert D. Walter Founder’s Award and the 2011 Distribution Management Award for Career Achievement. Neil graduated from Washington State University with a BA in Marketing. Neil recently relocated to the Pacific Northwest and resides with his wife of 35 years Kathy, and has two daughters, Becca and Kati. |
|
|
Brian Williams
Global Clients & Markets
PricewaterhouseCoopers International |
| |
Brian Williams advises executives at pharmaceutical and medical device companies on strategic and commercial risks, corporate and entrepreneurial ventures and innovation. He has nearly twenty years of investment, business development and strategy expertise within the healthcare industry.
Brian’s work at PwC provides senior executives with insights on:
- Entry strategies for new markets, adjacencies or new geographic territories
- Business model innovation that supports access to care, higher adherence rates or improved outcomes
- mhealth and ehealth strategy development and implementation
Prior to joining PwC, Brian served as an executive for two healthcare firms, including one early stage company where he quadrupled revenues in three years, leading to a sale of the company returning 10 times the invested capital. Brian also drove industry acceptance and market growth of a venture-backed, Silicon Valley-based SaaS-deployed pharmaceutical data management and performance analytics firm. Prior to these line management roles, he spent a decade as an investor and entrepreneur. As an investor, Brian co-founded two top quartile performing private equity funds as ranked by PwC's MoneyTree report, whose investments included novel therapeutics, market leading devices and diagnostics and new strategies for compliance and adherence. As an entrepreneur and advisor to entrepreneurs, he helped secure multiple funding rounds for novel technologies from the National Science Foundation and secured nearly $1 billion in private growth capital. Prior to his business ventures, Brian served as a speechwriter to a former two-term Governor of Indiana.
A graduate of Indiana University, Brian is a co-author of PwC’s “The New Gold Rush,” an analysis of non-traditional entrants into healthcare, a co-author of “Owning the Disease” as published in InVivo, December 2011, a solutions-based approach to disease management and he is a contributor to PwC’s “Pharma 2020” and its subsequent publications. He is a frequent speaker at industry events on the global dynamics of regulatory reform, revolution in care and of the personalization of care. |
|
|